Rather a derogatory posting. From little acorns big oak trees grow. They are proceeding in a logical manner and you start small. They know what they are doing, indeed the MD/CEO? was on the Neuren team when it was 10c on a good day and through their logical small start, methodical approach that stock went to $10+. Whilst we are doing the GLP preliminary work The US Army Walter Reed Centre is undergoing testwork as well and we should get a readout before too long, And yes, WR use rat(s) as well. WR is the LEADING brain injury research Centre in the USA. A positive result from their prelim work will hold us in good stead for FDA approval to go to Phase 1/2. After all, who would disagree with the US Army ! As for funding, an all clear from WR and no GLP issues would I expectasily funding from the US Army and/ or other agencies in the USA. The US Army has said Traumatic Brain Injury is their Number 1 issue when it comes to medical research. The risk/reward scenarion here is too compelling to ignore.
NYR Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)